iifl-logo-icon 1

Tatva Chintan Pharma Chem Ltd Share Price

1,173.5
(0.63%)
Jul 16, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open1,174
  • Day's High1,183.1
  • 52 Wk High1,772.4
  • Prev. Close1,166.2
  • Day's Low1,161
  • 52 Wk Low956.7
  • Turnover (lac)159.4
  • P/E93.37
  • Face Value10
  • Book Value313.84
  • EPS12.55
  • Mkt. Cap (Cr.)2,745.06
  • Div. Yield0.17
No Records Found

Tatva Chintan Pharma Chem Ltd KEY RATIOS

Sector

Chemicals

Open

1,174

Prev. Close

1,166.2

Turnover(Lac.)

159.4

Day's High

1,183.1

Day's Low

1,161

52 Week's High

1,772.4

52 Week's Low

956.7

Book Value

313.84

Face Value

10

Mkt Cap (₹ Cr.)

2,745.06

P/E

93.37

EPS

12.55

Divi. Yield

0.17

Tatva Chintan Pharma Chem Ltd Corporate Action

27 Aug 2023

12:00 AM

BookCloser

arrow

24 Apr 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

18 Aug 2023

12:00 AM

AGM

Announcement Date: 18 Aug, 2023

arrow

5 May 2023

12:00 AM

Dividend

Dividend Amount: 2

Record Date: 08 Sep, 2023

arrow

Tatva Chintan Pharma Chem Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Tatva Chintan Pharma Chem Ltd SHAREHOLDING SNAPSHOT

17 Jul, 2024|11:00 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 72.02%

Foreign: 0.00%

Indian: 72.02%

Non-Promoter- 14.00%

Institutions: 14.00%

Non-Institutions: 13.97%

Custodian: 0.00%

Share Price

Tatva Chintan Pharma Chem Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

22.17

22.17

20.09

8.04

Preference Capital

0

0

0

0

Reserves

482.62

446.71

141.85

106.41

Net Worth

504.79

468.88

161.94

114.45

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021

Revenue

291.18

yoy growth (%)

Raw materials

-145.71

As % of sales

50.04

Employee costs

-24.13

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021

Profit before tax

59.34

Depreciation

-6.73

Tax paid

-7.98

Working capital

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021

Growth matrix (%)

Revenue growth

Op profit growth

EBIT growth

Net profit growth

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

393.5

423.61

433.65

300.36

263.24

Excise Duty

0

0

0

0

0

Net Sales

393.5

423.61

433.65

300.36

263.24

Other Operating Income

0

0

0

0

0

Other Income

7.51

5.74

9.02

5.2

1.38

Tatva Chintan Pharma Chem Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Pidilite Industries Ltd

PIDILITIND

3,175.15

89.661,61,483.47354.320.52,588.88163.92

Linde India Ltd

LINDEINDIA

8,617.5

172.3473,470104.330630.07402.73

SRF Ltd

SRF

2,394.6

51.7870,949.28437.10.32,857.61353.96

Deepak Nitrite Ltd

DEEPAKNTR

2,799.1

102.3438,091.85115.680.27671.15216.61

Gujarat Fluorochemicals Ltd

FLUOROCHEM

3,332.65

87.4236,605.3286.010.091,043.2539.16

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Tatva Chintan Pharma Chem Ltd

Management

Register Office

Registrar Office

Chairman / Executive Director

Chintan Nitinkumar Shah

WTD & Executive Director

Ajaykumar Mansukhlal Patel

WTD & Executive Director

Shekhar Rasiklal Somani

Independent Non Exe. Director

Subhash Patel

Independent Non Exe. Director

Avani Rajesh Umatt

Independent Non Exe. Director

Manher Chinmanlal Desai

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

The Company was formerly incorporated as Tatva Chintan Pharma Chem Private Limited in India on 12 June 1996 under the Companies Act 2013. The status of the Company got converted from Private Limited into a Public Limited Company effective from 27 January 2021 and consequently, the name of Company also changed from Tatva Chintan Pharma Chem Private Limited to Tatva Chintan Pharma Chem Limited. The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is primarily engaged in manufacturing and selling of specialty chemicals, Pharma & Agro intermediates and Quaternary Ammonium Compounds (Quats). The Company is a globally recognized specialty chemical player with several market leading products in its portfolio. Considering the wide application of products, the Company supply products to leading global companies across diverse industries, like automotive, petroleum, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care and flavor and fragrances with over 1300 customers. Apart from customers in India, the Company export products across the globe including USA, China, Germany, Japan, South Africa and UK. The Company operate through two world class manufacturing facilities located at Dahej and Ankleshwar in Gujarat both of which are strategically located very close to the Hazira Port. These units provide the Company cost and logistics advantage and enabling seamless export and
Read More

Company FAQs

What is the Tatva Chintan Pharma Chem Ltd share price today?

Down Arrow

The Tatva Chintan Pharma Chem Ltd shares price on N/A is Rs.₹1171.75 today.

What is the Market Cap of Tatva Chintan Pharma Chem Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Tatva Chintan Pharma Chem Ltd is ₹2740.96 Cr. as of 16 Jul ‘24

What is the PE and PB ratio of Tatva Chintan Pharma Chem Ltd?

Down Arrow

The PE and PB ratios of Tatva Chintan Pharma Chem Ltd is 93.37 and 3.78 as of 16 Jul ‘24

What is the 52 Week High and Low of Tatva Chintan Pharma Chem Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Tatva Chintan Pharma Chem Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Tatva Chintan Pharma Chem Ltd is ₹958.15 and ₹1771 as of 16 Jul ‘24

What is the CAGR of Tatva Chintan Pharma Chem Ltd?

Down Arrow

Tatva Chintan Pharma Chem Ltd's CAGR for 5 Years at N/I%, 3 Years at -20.25%, 1 Year at -31.11%, 6 Month at -20.60%, 3 Month at -5.03% and 1 Month at 6.41%.

What is the shareholding pattern of Tatva Chintan Pharma Chem Ltd?

Down Arrow

The shareholding pattern of Tatva Chintan Pharma Chem Ltd is as follows:
Promoters - 72.02 %
Institutions - 14.00 %
Public - 13.98 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.